Reckitt relief unlikely in the short term says broker

Citigroup analysis indicates Reckitt Benckiser's second-quarter performance may align with peers, driven by emerging market strength, but a material stock rerating remains unlikely in the short term. Despite operational momentum, persistent US pricing issues, non-core division underperformance, and the unlikelihood of near-term catalysts—like successful divestments or legal resolution—mean the stock's 15% EV/EBITDA discount to peers will persist, offering long-term optionality rather than immediate upside.

Analysis

According to a Citigroup research note, Reckitt Benckiser's (LSE:RKT) upcoming second-quarter results are expected to show operational momentum in line with its household and personal care peers, buoyed by strength in core emerging markets such as China and India. However, this positive performance is likely to be counterbalanced by persistent pricing struggles in the United States and performance delays in its non-core Essential Health and Home divisions. The central issue for investors is the stock's valuation, which currently trades at a 15% discount to the sector on FY25 EV/EBITDA multiples. Closing this gap hinges on two significant catalysts that are deemed unlikely in the near term: the successful divestment of the non-core divisions at a favorable multiple, and a positive resolution to the company's ongoing legal overhang. Consequently, despite solid underlying business trends, the analysis suggests that a material rerating of the stock is not imminent, positioning Reckitt as a case of long-term optionality rather than a source of short-term upside.

Key Decisions for Investors

• Investors should recognize that realizing the value from Reckitt's 15% discount to peers is likely a long-term proposition, as the key catalysts for a rerating are not expected in the immediate future.
• It is critical to monitor any developments related to the divestment of the Essential Health and Home divisions or news concerning the company's legal issues, as these are the primary triggers for a potential revaluation.
• Ahead of the July 24th results, focus should be on the performance in emerging markets versus US pricing power to validate the core business's underlying strength, even as the broader investment case remains unchanged.